Literature DB >> 18939868

Concise synthesis of telmisartan via decarboxylative cross-coupling.

Lukas J Goossen1, Thomas Knauber.   

Abstract

An efficient synthesis of the angiotensin II receptor antagonist telmisartan is presented involving a decarboxylative cross-coupling of isopropyl phthalate (1) with 2-(4-chlorophenyl)-1,3-dioxolane (2c) as the key step (85% yield). The benzimidazole moiety is constructed regioselectively via a reductive amination-condensation sequence, replacing the previously published route via alkylation of the preformed benzimidazole. The product is obtained in an overall yield of 35% in a convergent synthesis with the longest sequence consisting of eight steps.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18939868     DOI: 10.1021/jo801937h

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  5 in total

1.  Efficient and improved synthesis of Telmisartan.

Authors:  A Sanjeev Kumar; Samir Ghosh; G N Mehta
Journal:  Beilstein J Org Chem       Date:  2010-03-11       Impact factor: 2.883

2.  An iodine/DMSO-catalyzed sequential one-pot approach to 2,4,5-trisubstituted-1H-imidazoles from α-methylene ketones.

Authors:  Janeeka Jayram; Vineet Jeena
Journal:  RSC Adv       Date:  2018-11-07       Impact factor: 3.361

3.  An improved synthesis of telmisartan via the copper-catalyzed cyclization of o-haloarylamidines.

Authors:  Junchi Zhang; Rui Li; Fuqiang Zhu; Changliang Sun; Jingshan Shen
Journal:  RSC Adv       Date:  2020-04-03       Impact factor: 3.361

Review 4.  Rational Design and Synthesis of AT1R Antagonists.

Authors:  Nikitas Georgiou; Vasileios K Gkalpinos; Spyridon D Katsakos; Stamatia Vassiliou; Andreas G Tzakos; Thomas Mavromoustakos
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

5.  Aqueous synthesis of 1-H-2-substituted benzimidazoles via transition-metal-free intramolecular amination of aryl iodides.

Authors:  Chunxia Chen; Chen Chen; Bin Li; Jingwei Tao; Jinsong Peng
Journal:  Molecules       Date:  2012-10-24       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.